Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03223610
Brief Title: Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma

First Submitted : July 19, 2017
First Submitted that Met QC Criteria : July 19, 2017
First Posted : July 21, 2017

Last Update Submitted that Met QC Criteria : December 11, 2019
Last Update Posted : December 12, 2019